Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Outside of a trial setting, retatrutide is not available for use in the UK
It is currently the only compound of its kind that has received FDA approval (under the name Vyleesi) for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women, further highlighting its importance as a research molecule
Avg weight loss (68 weeks): ~14.9% (STEP 1) Side Effects by Dose Level Side effects are dose-dependent and usually worst during the first 12 weeks after each dose increase
436,437 Ongoing clinical trials are rapidly advancing in this field, striving to achieve precise matching of treatment with the biological characteristics of each tumor (including tissue subtypes and molecular features) and individual patient conditions
Aim for at least 3 liters daily, more if you can tolerate it
US$ 21.13
US$ 29.71
US$ 26.06
US$ 27.46
US$ 28.99
US$ 28.50
US$ 28.71
